GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Chunlizhengda Medical Instruments Co Ltd (HKSE:01858) » Definitions » ROA %

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) ROA % : 11.20% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Beijing Chunlizhengda Medical Instruments Co ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Beijing Chunlizhengda Medical Instruments Co's annualized Net Income for the quarter that ended in Dec. 2023 was HK$425.2 Mil. Beijing Chunlizhengda Medical Instruments Co's average Total Assets over the quarter that ended in Dec. 2023 was HK$3,798.0 Mil. Therefore, Beijing Chunlizhengda Medical Instruments Co's annualized ROA % for the quarter that ended in Dec. 2023 was 11.20%.

The historical rank and industry rank for Beijing Chunlizhengda Medical Instruments Co's ROA % or its related term are showing as below:

HKSE:01858' s ROA % Range Over the Past 10 Years
Min: 5.92   Med: 13.19   Max: 23.2
Current: 5.92

During the past 11 years, Beijing Chunlizhengda Medical Instruments Co's highest ROA % was 23.20%. The lowest was 5.92%. And the median was 13.19%.

HKSE:01858's ROA % is ranked better than
74.68% of 861 companies
in the Medical Devices & Instruments industry
Industry Median: -1.91 vs HKSE:01858: 5.92

Beijing Chunlizhengda Medical Instruments Co ROA % Historical Data

The historical data trend for Beijing Chunlizhengda Medical Instruments Co's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Chunlizhengda Medical Instruments Co ROA % Chart

Beijing Chunlizhengda Medical Instruments Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.20 21.17 14.35 9.19 7.79

Beijing Chunlizhengda Medical Instruments Co Quarterly Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.50 - 6.33 11.20 6.01

Competitive Comparison of Beijing Chunlizhengda Medical Instruments Co's ROA %

For the Medical Devices subindustry, Beijing Chunlizhengda Medical Instruments Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Chunlizhengda Medical Instruments Co's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beijing Chunlizhengda Medical Instruments Co's ROA % distribution charts can be found below:

* The bar in red indicates where Beijing Chunlizhengda Medical Instruments Co's ROA % falls into.



Beijing Chunlizhengda Medical Instruments Co ROA % Calculation

Beijing Chunlizhengda Medical Instruments Co's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=303.878/( (3807.737+3991.813)/ 2 )
=303.878/3899.775
=7.79 %

Beijing Chunlizhengda Medical Instruments Co's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=425.24/( (3604.173+3991.813)/ 2 )
=425.24/3797.993
=11.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


Beijing Chunlizhengda Medical Instruments Co  (HKSE:01858) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=425.24/3797.993
=(Net Income / Revenue)*(Revenue / Total Assets)
=(425.24 / 1821.66)*(1821.66 / 3797.993)
=Net Margin %*Asset Turnover
=23.34 %*0.4796
=11.20 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Beijing Chunlizhengda Medical Instruments Co ROA % Related Terms

Thank you for viewing the detailed overview of Beijing Chunlizhengda Medical Instruments Co's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Business Description

Traded in Other Exchanges
Address
No. 10 Xinmi Xi Er Road, Southern District of Tongzhou, Economic Development Zone, Tongzhou District, Beijing, CHN
Beijing Chunlizhengda Medical Instruments Co Ltd is an orthopedic medical device company. It is engaged in the research, development, manufacture, and sale of orthopedic medical devices, including joint prosthesis products and spinal products. The products offered by the company are classified into three categories, namely Standard joint prosthesis products, Custom joint prosthesis products, and Spinal products. It operates in the business segment of manufacture and trading of surgical implants, instruments and related products.
Executives
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co. 2502 Approved lending agent
Citigroup Inc. 2502 Approved lending agent
Fidelity China Special Situations Plc 2101 Beneficial owner
Taiping Assets Management (hk) Company Limited 2102 Investment manager
Taiping Trustees Limited 2301 Trustee

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Headlines

No Headlines